Antibody modified-silver nanoparticles for colorimetric immuno sensing of Aβ(1–40/1–42) based on the interaction between β-amyloid and Cu2+
- 1 October 2016
- journal article
- Published by Elsevier BV in Sensors and Actuators B: Chemical
- Vol. 234, 63-69
- https://doi.org/10.1016/j.snb.2016.04.159
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (21435005, 21205111)
This publication has 45 references indexed in Scilit:
- The case for rejecting the amyloid cascade hypothesisNature Neuroscience, 2015
- Detection of Misfolded Aβ Oligomers for Sensitive Biochemical Diagnosis of Alzheimer’s DiseaseCell Reports, 2014
- Alzheimer Mechanisms and Therapeutic StrategiesCell, 2012
- Cerebrospinal Fluid Levels ofβ-Amyloid 1-42, but Not of Tau, Are Fully Changed Already 5 to 10 Years Before the Onset of Alzheimer DementiaArchives of General Psychiatry, 2012
- Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptideNature Reviews Molecular Cell Biology, 2007
- The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to TherapeuticsScience, 2002
- Clearance of Alzheimer’s amyloid-β1-40 peptide from brain by LDL receptor–related protein-1 at the blood-brain barrierJCI Insight, 2000
- Neuropathology of Alzheimer’s disease: what is new since A. Alzheimer?Archiv Fur Psychiatrie Und Nervenkrankheiten, 1999
- Release of Excess Amyloid β Protein from a Mutant Amyloid β Protein PrecursorScience, 1993
- Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein productionNature, 1992